Please check your internet connection and try again.
## Diadzein + Genistein + Palmitoylethanolamide
## Overview
This combination product contains three dietary supplements:
* **Daidzein and Genistein:** Isoflavones derived from soybeans, acting as phytoestrogens.
* **Palmitoylethanolamide (PEA):** An endogenous fatty acid amide with potential anti-inflammatory and analgesic properties.
These agents are often used for menopausal symptom management, bone health, and pain relief. Evidence for efficacy in these areas is variable and often based on supplement studies rather than rigorous clinical trials.
## Primary Indications
* Menopausal symptom management (e.g., hot flashes).
* Bone health support.
* Pain management (particularly for chronic or neuropathic pain, often with PEA).
## Adult Dosing
Dosing varies widely among products. Typical suggested ranges include:
* **Daidzein:** 10-50 mg daily.
* **Genistein:** 10-50 mg daily.
* **Palmitoylethanolamide (PEA):** 300-1200 mg once or twice daily.
*Note: Specific product formulations and concentrations will dictate the overall daily intake of each component.*
## Pediatric Dosing
There is no established pediatric dosing for this combination. Use in pediatric populations is not recommended.
## Dose Adjustments
No specific dose adjustments are typically recommended based on renal or hepatic impairment, as these are dietary supplements. However, caution is advised in patients with pre-existing conditions.
## Contraindications
* Known hypersensitivity to any component.
* Pregnancy and breastfeeding (due to lack of safety data and potential hormonal effects).
* Individuals with hormone-sensitive cancers (e.g., breast, uterine, ovarian cancer, prostate cancer) should exercise extreme caution or avoid use due to the phytoestrogenic activity of daidzein and genistein.
## Adverse Effects
* **Daidzein & Genistein:** Gastrointestinal upset (nausea, diarrhea), breast tenderness, menstrual irregularities.
* **Palmitoylethanolamide (PEA):** Generally well-tolerated. May include gastrointestinal upset, headache, or dizziness.
## Key Drug Interactions
* **Hormone Therapies:** Potential additive effects or interference with hormone replacement therapy (HRT) or oral contraceptives.
* **Tamoxifen and other SERMs:** Potential for interactions due to estrogenic/antiestrogenic activity.
* **Anticoagulants/Antiplatelets:** Some isoflavones may have mild antiplatelet effects; caution with concomitant use.
* **Immunosuppressants:** PEA's role in the endocannabinoid system may theoretically interact with other modulators.
## Monitoring
* Symptom relief (e.g., frequency and severity of hot flashes, pain levels).
* Menstrual cycle regularity.
* Consider baseline and periodic assessment for hormone-sensitive conditions if patient is at risk.
## Clinical Pearls
* Onset of action for menopausal symptom relief can take several weeks.
* Product quality and bioavailability can vary significantly between manufacturers.
* The use of these agents should be discussed with a healthcare provider, especially in individuals with underlying health conditions or those taking other medications.
* PEA is often micronized to improve absorption.
***
**Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always verify the most current prescribing information and consult with a qualified healthcare provider before making any treatment decisions.
